All News

A new pharmacy-based program in rural America is potentially identifying and saving thousands of patients from cardiovascular disease.

As reimbursement rates continue to erode and operating costs climb, independent pharmacy owners are being forced to think like CFOs—not just clinicians.

Researchers explore the role of pharmacists in medication reconciliation and patient counseling.

New intranasal etripamil lets adults self-treat sudden paroxysmal supraventricular tachycardia episodes.

In part 2, McMahan contextualizes the recent FTC-Caremark settlement with some of the industry’s major reform efforts in recent history.

Dispensary of Hope delivers donated medications to uninsured patients, cutting emergency room visits and redefining pharmacy’s role in access.

Pharmacies are expanding vaccine access for flu, COVID, and other shots while debunking safety myths and adding test-to-treat services to improve patient care.

Researchers map the structural components that allow for a more patient-centered approach across pharmacist-led management.

Pharmacist-backed travel kit picks tackle motion sickness, dehydration, and stomach upsets for on-the-go relief.

The White House and the American Academy of Pediatrics leave pharmacists navigating 2 competing sets of vaccine guidance for the upcoming season.

This episode provides an introspective look at the people in pharmacy who are the hardest to lead toward a path of success.

A decades-long research effort in mRNA-produced licensed vaccines targets influenza, respiratory syncytial virus, cytomegalovirus, HIV, and cancer.

Separating medical and nonmedical products leads to a variety of better inventory decisions in community pharmacies.

Rae McMahan joins to provide key insights and updates on developing action between CVS Caremark, the FTC, and the rest of the pharmacy benefits industry.

When it comes to pain management, safer options such as acetaminophen have emerged as better choices for older adults.

Community pharmacies deliver personalized travel medicine, helping travelers leave protected and prepared.

Researchers aimed to better understand the prominence of vaccine failures and breakthrough infections of pediatric pneumoccoal immunization.

Data show possible but insignificant reduction in hypertensive disorders of pregnancy after periconceptional or first-trimester GLP-1 exposure.

From their originally intended purposes to the growing indications showing promise in development, GLP-1 and GIP receptor agonists have evolved rapidly.

Community pharmacists deliver travel vaccine clinics, navigate entry rules, and update routine shots with new guidance on polio, measles, and chikungunya.

Despite significant progress made in the US opioid epidemic, systemic change is necessary to move pain management forward across health care.

Data on excess deaths in high-income countries show the male mortality disadvantage during COVID-19 is concentrated in the pandemic's earliest phase.

Counseling, team-based care, and tailored pharmacy interventions remain among the most effective tools against medication nonadherence in the United States.

The approval gives pharmacists a new, nonegg-based seasonal influenza option for adults 50 and older ahead of the 2026-2027 flu season.

Empathy amongst patients’ most trusted health care providers can translate to better outcomes and health care delivery.

Oveporexton, an oral orexin receptor 2 agonist, is the first medicine to restore orexin signaling rather than manage symptoms of the rare sleep disorder.

Following multiple exits in this role throughout President Trump’s second term, the new director’s tenure is reported to be permanent going forward.

This medication is the first FDA-approved OTC innovation in the cold and flu category in 14 years.